CD59型
阵发性夜间血红蛋白尿
药品
多发性硬化
药物作用
功能(生物学)
生物
治疗窗口
癌症研究
免疫学
医学
细胞生物学
药理学
免疫系统
补体系统
作者
Sarmoko Sarmoko,Monica Ramadhanti,Nur Ayunie Zulkepli
出处
期刊:Gene Reports
[Elsevier BV]
日期:2023-04-03
卷期号:31: 101772-101772
被引量:4
标识
DOI:10.1016/j.genrep.2023.101772
摘要
CD59 is a major inhibitor of membrane attack complex (MAC) formation, which is anchored to the cell membrane by glycosylphosphatidylinositol (GPI). The protein is widely expressed in most human tissues. Several studies have reported the involvement of CD59 with several diseases such as paroxysmal nocturnal hemoglobinuria (PNH), cancer, peripheral demyelination, multiple sclerosis, diabetes mellitus, and viral infections. Herein, we summarized the biological structure and expression pattern of CD59, and its biological function, and focused on discussing the involvement of CD59 in several diseases and its potential for therapeutic use.
科研通智能强力驱动
Strongly Powered by AbleSci AI